Micromedic Technologies / Dr. Lal PathLabs Pilot
Micromedic Technologies has created CellDetect®, a staining technology that combines color and morphology to screen women who are at risk of developing cervical cancer. In this pilot, cervical specimens collected at Dr. Lal PathLabs were analyzed using CellDetect® to simplify and expedite the interpretation of microscopic slides and boost the detection of early stage and pre-cancer lesions.
March 2017- December 2017
Dr. Lal PathLabs Ltd. National Reference Laboratory, Rohini, New Delhi, India
170 patients enrolled
CellDetect® color feature and its ability to highlight endocervical/abnormal cells was considered a useful tool for both negative and suspicious cases.
Adding color discrimination to morphology in slide analysis improved efficiency of screening process. Turnaround time per slide was 34% shorter with CellDetect® than with Pap.
The pilot highlighted CellDetect’s capabilities and also demonstrated that remote training and technical support are effective and sufficient.
The pilot enabled Micromedic to learn how to navigate regulatory and import requirements and collect local data in India. The pilot also helped the company know the applicability of their other products, including applications related to bladder cancer. Based on local evidence and experience accumulated through the pilot, Micromedic has signed a local partner to distribute their products in India.